Skip to main content
Journal cover image

Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.

Publication ,  Journal Article
Mikati, MA; Zeinieh, M; Habib, RA; El Hokayem, J; Rahmeh, A; El Sabban, M; Usta, J; Dbaibo, G
Published in: Epilepsy Res
October 2008

Status epilepticus (SE) induces a number of events leading to programmed cell death (PCD). The aim of our work is to study the time sequence of activation of different factors in experimental SE (intraperitoneal kainic acid (KA) model). We studied ceramide, a known mediator of apoptosis in multiple models, sphingomyelinases (SMases), enzymes that break down sphingomyelin and increase ceramide thus leading to apoptosis in many models, Bcl(2), Bax, and caspase-3. SE induced a sustained ceramide increase starting 2h after kainic acid injection followed by an increase in Bax protein at 6 and 12h, and the appearance of caspase-3-activated fragment (caspase-3a) immunostaining and TUNEL positivity at 12h. Status epilepticus also induced an increase in acidic and neutral sphingomyelinases that preceded (acidic sphingomyelinase) and parallelled (acidic and neutral sphingomyelinase) the increases in ceramide. These data suggest that, in this model, Bax is activated early in the process and that its increase is sustained till 12h after kainic acid injection which is the time of first appearance of caspase-3 activation and TUNEL positivity, and that SMases contribute to increases in ceramide levels during and after status epilepticus.

Duke Scholars

Published In

Epilepsy Res

DOI

ISSN

0920-1211

Publication Date

October 2008

Volume

81

Issue

2-3

Start / End Page

161 / 166

Location

Netherlands

Related Subject Headings

  • bcl-2-Associated X Protein
  • Time Factors
  • Status Epilepticus
  • Sphingomyelin Phosphodiesterase
  • Rats, Sprague-Dawley
  • Rats
  • Proto-Oncogene Proteins c-bcl-2
  • Neurology & Neurosurgery
  • Kainic Acid
  • In Situ Nick-End Labeling
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mikati, M. A., Zeinieh, M., Habib, R. A., El Hokayem, J., Rahmeh, A., El Sabban, M., … Dbaibo, G. (2008). Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus. Epilepsy Res, 81(2–3), 161–166. https://doi.org/10.1016/j.eplepsyres.2008.05.009
Mikati, Mohamad A., Michele Zeinieh, Ralph Abi Habib, Jimmy El Hokayem, Amal Rahmeh, Marwan El Sabban, Julnar Usta, and Ghassan Dbaibo. “Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.Epilepsy Res 81, no. 2–3 (October 2008): 161–66. https://doi.org/10.1016/j.eplepsyres.2008.05.009.
Mikati MA, Zeinieh M, Habib RA, El Hokayem J, Rahmeh A, El Sabban M, et al. Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus. Epilepsy Res. 2008 Oct;81(2–3):161–6.
Mikati, Mohamad A., et al. “Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.Epilepsy Res, vol. 81, no. 2–3, Oct. 2008, pp. 161–66. Pubmed, doi:10.1016/j.eplepsyres.2008.05.009.
Mikati MA, Zeinieh M, Habib RA, El Hokayem J, Rahmeh A, El Sabban M, Usta J, Dbaibo G. Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus. Epilepsy Res. 2008 Oct;81(2–3):161–166.
Journal cover image

Published In

Epilepsy Res

DOI

ISSN

0920-1211

Publication Date

October 2008

Volume

81

Issue

2-3

Start / End Page

161 / 166

Location

Netherlands

Related Subject Headings

  • bcl-2-Associated X Protein
  • Time Factors
  • Status Epilepticus
  • Sphingomyelin Phosphodiesterase
  • Rats, Sprague-Dawley
  • Rats
  • Proto-Oncogene Proteins c-bcl-2
  • Neurology & Neurosurgery
  • Kainic Acid
  • In Situ Nick-End Labeling